sarms

About RAD-140

RAD-140 is a SARM developed by Radius Health, Inc. for treatment of conditions like muscle wasting and breast cancer [1]. It exerts anabolic activity in muscle and connective tissue with little effect on the prostate and seminal vesicles. In addition, it may selectively compete and antagonize testosterone in these tissues. Scientists administered testosterone proprionate at […]

About LGD-4033

LGD-4033 is a 3rd generation non-steroidal oral SARM with a high affinity for the androgen receptor (Ki of ~1 nM). It is currently the second most popular SARM on the market. Unlike testosterone which exerts anabolic effects by the same pathway, LGD-4033 has high selectivity for receptors in skeletal muscle, bone, and connective tissue, with […]